Around $105.2 million bought by Armenian banks last week

YEREVAN, February 12. /ARKA/. Armenia’s commercial banks bought around $105.2 million from the local foreign currency market on February 5 to 9 at the average weighted exchange rate of 481.43 drams per one USD, the Central Bank of Armenia reported on Monday.

It said the banks also bought 8.7 million euros and 730 million Russian rubles at the average weighted exchange rates of 594 and 8.41 drams per one euro and one ruble respectively.

The banks also sold about $69.2 million, € 18.5 million and 572.1 million rubles at average weighted exchange rates of 482.8, 598.65 and 8.0 drams respectively.

No dollar exchange transactions have been effected at NASDAQ OMX Armenia stock exchange over the mentioned period.

In addition, from January 29 to February 4, the banks have provided 59.4 billion drams worth loans in the national currency and $86.9 million worth loans in USD. ($ 1- AMD 483.11 drams). –0—-

spot_img

POPULAR

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

LATEST NEWS

spot_imgspot_imgspot_img